Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences ...Middle East

Acquisition significantly expands Flagship's portfolio of biomarker and analytics services BROOMFIELD, Colo., Aug. 31, 2022 /PRNewswire/ -- Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions®...

Read More Details
Finally We wish PressBee provided you with enough information of ( Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences )

Also on site :

• Elon Musk commits to leading Tesla for next five years
• Elon Musk confirms Tesla plan for robotaxis on Austin roads in June
• Expedera's Origin Evolution NPU IP Brings Generative AI to Edge Devices